Skip to content

Yoga for wellness: Impact of Asana and Pranayama on Premenstrual Syndrome (PMS)

Effect of Asana and Pranayama on Autonomic Function Tests in Young Females with Premenstrual Syndrome - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060710
Enrollment
49
Registered
2023-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Asana and Pranayama (Yoga): Following yogic techniques will be practiced- 1. Swastikasana 2. Vajrasana 3. Supta Vajrasana 4. Tadasana 5. Trikonasana 6. Prasiratpadottana 7. Janushirshas

Sponsors

Anushka Pai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 49 apparently healthy female subjects volunteering for the study. Age group: 18 – 36 years History of regular menstrual cycle Females who understand English With occurrence of PMS (According to premenstrual syndrome scale developed by Gencdogan, having total score = 80)

Exclusion criteria

Exclusion criteria: Females suffering from medical or psychiatric/somatic/ gynecological/ hormonal disorders Females who are not using any medication or contraceptive pills Females involved in any kind of athletic programme or practicing other forms of yogic exercises • Female subjects who were unable to perform yoga due to any reason

Design outcomes

Primary

MeasureTime frame
For HRV assessment i. Time domain parameters: Mean-RR (mean of RR interval) SDNN (standard deviation [SD] of RR interval) RMSSD (the square root of the mean of the sum of the squares of the differences between adjacent NN intervals) NN50 (the number of pairs of adjacent NN intervals differing by >50 ms in the entire recording) pNN50 (the percentage of NN50 counts, given by NN50 count divided by total number of all NN intervals) ii. Frequency domain parameters: TP -Total power HF- High frequency (0.15–0.4 Hz) LF -Low frequency (0.04–0.15 Hz) LF in normalized units (LFnu) HF in normalized units (HFnu) LF/HF ratioTimepoint: T0- Baseline T1- 3 months After commencement of intervention

Secondary

MeasureTime frame
Resting Heart Rate Deep Breathing Test Valsalva maneuver Isometric Handgrip test Orthostatic HypotensionTimepoint: T0- Baseline T1- 3 months After commencement of intervention

Countries

India

Contacts

Public ContactAnushka Pai

Kasturba Medical College, MAHE, Manipal

manjula.sd@manipal.edu8197579529

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026